The second publication. Nothing new here, but wort
Post# of 145338
![](/assets/46931549/no_avatar_available_thumb.jpg)
“Leronlimab, reduced aGvHD in a dose-response fashion in a xenogeneic mouse model of aGvHD (NOD-scid IL2Rynull mice transplanted with human bone marrow stem cells) without significantly altering engraftment.”
From 2018…
https://pubmed.ncbi.nlm.nih.gov/29128556/
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)